Advertisement
Advertisement

CRVO

CRVO logo

CervoMed Inc. Common Stock

3.26
USD
Sponsored
-0.46
-12.37%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

3.25

-0.01
-0.28%

CRVO Earnings Reports

Positive Surprise Ratio

CRVO beat 14 of 31 last estimates.

45%

Next Report

Date of Next Report
Aug 06, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.81
Implied change from Q1 26 (Revenue/ EPS)
--
/
-5.81%
Implied change from Q2 25 (Revenue/ EPS)
-100.00%
/
+15.71%

CervoMed Inc. Common Stock earnings per share and revenue

On May 15, 2026, CRVO reported earnings of -0.86 USD per share (EPS) for Q1 26, missing the estimate of -0.79 USD, resulting in a -8.09% surprise. Revenue reached --, compared to an expected 61.20 thousand, with a -100.00% difference. The market reacted with a -8.51% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 7 analysts forecast an EPS of -0.81 USD, with revenue projected to reach -- USD, implying an decrease of -5.81% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
For Q1 2026, CervoMed Inc. Common Stock reported EPS of -$0.86, missing estimates by -8.09%, and revenue of $0.00, -100% below expectations.
The stock price moved down -8.51%, changed from $3.76 before the earnings release to $3.44 the day after.
The next earning report is scheduled for Aug 06, 2026.
Based on 7 analysts, CervoMed Inc. Common Stock is expected to report EPS of -$0.81 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement